MHLW to Set Up Study Group to Discuss Legislation to Regulate Clinical Research “by April at the Latest”

In the wake of the scandal surrounding investigator-initiated trials of Novartis Pharma’s angiotensin receptor blocker Diovan (valsartan), Health Minister Norihisa Tamura announced at a meeting of the upper house’s Budget Committee on March 4 that the Ministry of Health, Labor...read more